{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:41:54Z","timestamp":1777560114136,"version":"3.51.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Emerg Med"],"DOI":"10.1186\/s12873-025-01288-8","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:18:14Z","timestamp":1752538694000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Current practices and knowledge of adenosine administration for paroxysmal supraventricular tachycardia: a multi-province survey in Chinese emergency departments"],"prefix":"10.1186","volume":"25","author":[{"given":"Hao","family":"Zou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanguan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaopeng","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaohong","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruikai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"issue":"19","key":"1288_CR1","doi-asserted-by":"publisher","first-page":"e015910","DOI":"10.1161\/JAHA.120.015910","volume":"9","author":"NC Sacks","year":"2020","unstructured":"Sacks NC, Everson K, Emden MR, et al. Disparities in the management of newly diagnosed paroxysmal supraventricular tachycardia for women versus men in the united States. J Am Heart Assoc. 2020;9(19):e015910. https:\/\/doi.org\/10.1161\/JAHA.120.015910.","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"1288_CR2","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.hrthm.2015.03.046","volume":"12","author":"DG Katritsis","year":"2015","unstructured":"Katritsis DG, Josephson ME. Differential diagnosis of regular, narrow-QRS tachycardias. Heart Rhythm. 2015;12(7):1667\u201376. https:\/\/doi.org\/10.1016\/j.hrthm.2015.03.046.","journal-title":"Heart Rhythm"},{"issue":"13","key":"1288_CR3","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1016\/j.jacc.2015.08.856","volume":"67","author":"RL Page","year":"2016","unstructured":"Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC\/AHA\/HRS guideline for the management of adult patients with supraventricular tachycardia: A report of the American college of cardiology\/american heart association task force on clinical practice guidelines and the heart rhythm society. J Am Coll Cardiol. 2016;67(13):e27\u2013115. https:\/\/doi.org\/10.1016\/j.jacc.2015.08.856.","journal-title":"J Am Coll Cardiol"},{"issue":"16suppl2","key":"1288_CR4","doi-asserted-by":"publisher","first-page":"S366","DOI":"10.1161\/CIR.0000000000000916","volume":"142","author":"AR Panchal","year":"2020","unstructured":"Panchal AR, Bartos JA, Caba\u00f1as JG, et al. Part 3: adult basic and advanced life support: 2020 American heart association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2020;142(16suppl2):S366\u2013468. https:\/\/doi.org\/10.1161\/CIR.0000000000000916.","journal-title":"Circulation"},{"issue":"5","key":"1288_CR5","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/eurheartj\/ehz467","volume":"41","author":"J Brugada","year":"2020","unstructured":"Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC guidelines for the management of patients with supraventricular tachycardiathe task force for the management of patients with supraventricular tachycardia of the European society of cardiology (ESC). Eur Heart J. 2020;41(5):655\u2013720. https:\/\/doi.org\/10.1093\/eurheartj\/ehz467.","journal-title":"Eur Heart J"},{"issue":"10","key":"1288_CR6","doi-asserted-by":"publisher","first-page":"CD005154","DOI":"10.1002\/14651858.CD005154.pub4","volume":"2017","author":"S Alabed","year":"2017","unstructured":"Alabed S, Sabouni A, Providencia R, Atallah E, Qintar M, Chico TJ. Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia. Cochrane Database Syst Rev. 2017;2017(10):CD005154. https:\/\/doi.org\/10.1002\/14651858.CD005154.pub4.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1288_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.7861\/clinmed.cme.20.1.3","volume":"20","author":"ID Kotadia","year":"2020","unstructured":"Kotadia ID, Williams SE, O\u2019Neill M. Supraventricular tachycardia: an overview of diagnosis and management. Clin Med Lond Engl. 2020;20(1):43\u20137. https:\/\/doi.org\/10.7861\/clinmed.cme.20.1.3.","journal-title":"Clin Med Lond Engl"},{"issue":"10005","key":"1288_CR8","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/S0140-6736(15)61485-4","volume":"386","author":"A Appelboam","year":"2015","unstructured":"Appelboam A, Reuben A, Mann C, et al. Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial. Lancet Lond Engl. 2015;386(10005):1747\u201353. https:\/\/doi.org\/10.1016\/S0140-6736(15)61485-4.","journal-title":"Lancet Lond Engl"},{"issue":"16","key":"1288_CR9","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1093\/eurheartj\/ehw455","volume":"39","author":"DG Katritsis","year":"2018","unstructured":"Katritsis DG, Boriani G, Cosio FG, et al. European heart rhythm association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by heart rhythm society (HRS), Asia-Pacific heart rhythm society (APHRS), and sociedad Latinoamericana de estimulaci\u00f3n cardiaca y electrofisiologia (SOLAECE). Eur Heart J. 2018;39(16):1442\u20135. https:\/\/doi.org\/10.1093\/eurheartj\/ehw455.","journal-title":"Eur Heart J"},{"issue":"11","key":"1288_CR10","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/BF01972885","volume":"153","author":"D De Wolf","year":"1994","unstructured":"De Wolf D, Rondia G, Verhaaren H, Matthys D. Adenosine-tri-phosphate treatment for supraventricular tachycardia in infants. Eur J Pediatr. 1994;153(11):793\u20136. https:\/\/doi.org\/10.1007\/BF01972885.","journal-title":"Eur J Pediatr"},{"issue":"6","key":"1288_CR11","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1159\/000021030","volume":"15","author":"JH Dangel","year":"2000","unstructured":"Dangel JH, Roszkowski T, Bieganowska K, Kubicka K, Ganowicz J. Adenosine triphosphate for cardioversion of supraventricular tachycardia in two hydropic fetuses. Fetal Diagn Ther. 2000;15(6):326\u201330. https:\/\/doi.org\/10.1159\/000021030.","journal-title":"Fetal Diagn Ther"},{"issue":"2","key":"1288_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/s0196-0644(94)70128-8","volume":"24","author":"M Gausche","year":"1994","unstructured":"Gausche M, Persse DE, Sugarman T, et al. Adenosine for the prehospital treatment of paroxysmal supraventricular tachycardia. Ann Emerg Med. 1994;24(2):183\u20139. https:\/\/doi.org\/10.1016\/s0196-0644(94)70128-8.","journal-title":"Ann Emerg Med"},{"issue":"2","key":"1288_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.7326\/0003-4819-113-2-104","volume":"113","author":"JP DiMarco","year":"1990","unstructured":"DiMarco JP, Miles W, Akhtar M, et al. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The adenosine for PSVT study group. Ann Intern Med. 1990;113(2):104\u201310. https:\/\/doi.org\/10.7326\/0003-4819-113-2-104.","journal-title":"Ann Intern Med"},{"key":"1288_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ajem.2024.08.044","volume":"85","author":"N Krug","year":"2024","unstructured":"Krug N, Baize P, Barre S, Barnes R, Weigartz K. Comparison of initial adenosine dose conversion rate for supraventricular tachycardia in the emergency department. Am J Emerg Med. 2024;85:117\u201322. https:\/\/doi.org\/10.1016\/j.ajem.2024.08.044.","journal-title":"Am J Emerg Med"}],"container-title":["BMC Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12873-025-01288-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12873-025-01288-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12873-025-01288-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:18:15Z","timestamp":1752538695000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcemergmed.biomedcentral.com\/articles\/10.1186\/s12873-025-01288-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1288"],"URL":"https:\/\/doi.org\/10.1186\/s12873-025-01288-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6509758\/v1","asserted-by":"object"}]},"ISSN":["1471-227X"],"issn-type":[{"value":"1471-227X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"23 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of Zhongnan Hospital, Wuhan University (Approval No. 2025123\u00a0K) and conducted in accordance with the Declaration of Helsinki. All participants provided written informed consent to participate in this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed to publica this article to this journal. Not applicable (this study does not involve the publication of identifying images or personal\/clinical details of participants). The questionnaire was developed specifically for this study and has not been published elsewhere. The questionnaire is in Chinese, and the English translation is provided in the Supplementary File (English version of the questionnaire).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"125"}}